Research ArticleOMERACT 12 — International Consensus Conference on Outcome Measures in Rheumatology, Budapest, Hungary, May 7–11, 2014
Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative
Jasvinder A. Singh, Michael Dohm, Andrew P. Sprowson, Peter D. Wall, Bethan L. Richards, Laure Gossec, Gillian A. Hawker, Daniel L. Riddle and Rachelle Buchbinder
The Journal of Rheumatology December 2015, 42 (12) 2496-2502; DOI: https://doi.org/10.3899/jrheum.141201
Jasvinder A. Singh
From the Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; University of Arizona, Tucson, Arizona,
USA; Warwick Clinical Trials Unit, University of Warwick, Coventry,
UK; Institute of Rheumatology and Orthopedics, Royal Prince Alfred Hospital; Sydney Medical School, University of Sydney, Sydney,
Australia; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d’Epidémiologie et de Santé Publique; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris,
France; Department of Medicine and Women’s College Hospital, University of Toronto, Toronto, Ontario,
Canada; Virginia Commonwealth University, Richmond, Virginia,
USA; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne; Monash Department of Clinical Epidemiology, Cabrini Hospital, Melbourne, Victoria,
Australia.
Michael Dohm
Andrew P. Sprowson
Peter D. Wall
Bethan L. Richards
Laure Gossec
Gillian A. Hawker
Daniel L. Riddle

Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 12
1 Dec 2015
Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative
Jasvinder A. Singh, Michael Dohm, Andrew P. Sprowson, Peter D. Wall, Bethan L. Richards, Laure Gossec, Gillian A. Hawker, Daniel L. Riddle, Rachelle Buchbinder
The Journal of Rheumatology Dec 2015, 42 (12) 2496-2502; DOI: 10.3899/jrheum.141201
Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative
Jasvinder A. Singh, Michael Dohm, Andrew P. Sprowson, Peter D. Wall, Bethan L. Richards, Laure Gossec, Gillian A. Hawker, Daniel L. Riddle, Rachelle Buchbinder
The Journal of Rheumatology Dec 2015, 42 (12) 2496-2502; DOI: 10.3899/jrheum.141201
Jump to section
- Article
- Abstract
- Step 1. Systematic Reviews and Studies to Identify Gaps in Outcome Measurement in TJR Trials and Their Methodological Quality and Application of OMERACT Filter 2.0 to the Development of Outcomes
- Step 2. Active Patient Engagement in the Validation Process
- Step 3. Involve Multistakeholder International Collaborators Interested in TJR Outcome
- Step 4. Make a Working Group of TJR Trialists, Registry Leaders, Patients, and Methodologists
- Step 5. Conduct Delphi and Consensus Meetings Online and In-person to Develop Data-driven Consensus for Core Domains for Patients with Endstage Refractory Arthritis Seeking TJR
- Step 6. Develop a Core Domain Set for Endorsement by the Larger Community of Stakeholders
- Step 7. Do TJR Outcome Measures Meet Truth, Discrimination, and Feasibility?
- Next Steps
- Acknowledgment
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics
- References
- eLetters